What are the clinical consequences of anemia in patients with chronic heart failure?

Journal of Cardiac Failure

Volumn 10, Issue 1 SUPPL., 2004, Pages

  McMurray, John J V ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

morbidity; mortality; Outcomes; prognosis

Indexed keywords

ANEMIA; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EXERCISE TOLERANCE; HEART FAILURE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MEDICAL SOCIETY; PARAMETER; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL RATE; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; MORBIDITY; MORTALITY; REVIEW;

HEMOGLOBIN;

ANEMIA; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HEMOGLOBINS; HUMANS; MORBIDITY; SURVIVAL RATE;

EID: 3042748149     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.01.001     Document Type: Article

References (20)

1. Szachniewicz J., Petruk-Kowalczyk J., Majda J., Kaczmarek A., Reczuch K., Kalra P.R., et al. Anemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol. 90:2003;303-308
2. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 39:2002;1780-1786
3. Mozaffarian D., Nye R., Levy W.C. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 41:2003;1933-1939
4. Kalra P.R., Collier T., Cowie M.R., Fox K.F., Wood D.A., Poole-Wilson P.A., et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet. 362:2003;211-212
5. Kalra P.R., Bolger A.P., Francis D.P., Genth-Zotz S., Sharma R., Ponikowski P.P., et al. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol. 91:2003;888-891
6. Kosiborod M., Smith G.L., Radford M.J., Foody J.M., Krumholz H.M. The prognostic importance of anemia in patients with heart failure. Am J Med. 114:2003;112-119
7. Golden J.S., Fallick C.C., Josephson S.R., Langford M.C., Morikawa S.J., Monson E.A., et al. Baseline hematocrit predicts clinical outcomes in heart failure. Circulation. 106:(Suppl):2002;II-680-II-681
8. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., Salem D.N., Levey A.S., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 38:2001;955-962
9. McClellan W.M., Flanders W.D., Langston R.D., Jurkovitz C., Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol. 13:2002;1928-1936
10. Androne A.S., Katz S.D., Lund L., LaManca J., Hudaihed A., Hryniewicz K., et al. Hemodilution is common in patients with advanced heart failure. Circulation. 107:2003;226-229
11. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12, 065 patients with new-onset heart failure. Circulation. 107:2003;223-225
12. Anker S.D., Sharma R., Fancis D., Pitt B., Poole-Wilson P.A., Coats A.J. Anemia and survival in 3044 patients with chronic heart failure (CHF) in the ELITE II trial. Circulation. 106:(Suppl):2002;II-472
13. Herzog C.A., Li S., Collins A.J. The impact of congestive heart failure (CHF), chronic kidney disease (CKD), and anemia on survival in the Medicare population. Circulation. 106;19:(Suppl 2):2002;II-472-II-472
14. Wisniacki N., Aimson P., Lye M. Is anemia a cause or a consequence of heart failure in the elderly. Heart. 85:(Suppl 1):2001;P4
15. Maggioni A.P., Latini R., Anand I., Barlera S., Gonzini L., Opasich C., et al. Prevalence and prognostic role of anemia in patients with heart failure in the IN-CHF Registry and the Val-HeFT trial. Eur Heart J. 4:(Suppl):2002;280
16. Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 102:2000;203-210
17. Drazner M.H., Rame J.E., Stevenson L.W., Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 345:2001;574-581
18. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 36:2000;1587-1593
19. Stevenson L.W., Tillisch J.H., Hamilton M., Luu M., Chelimsky-Fallick C., Moriguchi J., et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 66:1990;1348-1354
20. Besarab A., Bolton W.K., Browne J.K., Egrie J.C., Nissenson A.R., Okamoto D.M., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 339:1998;584-590